Literature DB >> 15228292

Conformationally constrained analogues of diacylglycerol. 24. Asymmetric synthesis of a chiral (R)-DAG-lactone template as a versatile precursor for highly functionalized DAG-lactones.

Ji-Hye Kang1, Maqbool A Siddiqui, Dina M Sigano, Krzysztof Krajewski, Nancy E Lewin, Yongmei Pu, Peter M Blumberg, Jeewoo Lee, Victor E Marquez.   

Abstract

[structure: see text] Commercially available 2-methylenepropane-1,3-diol was converted to chiral epoxide (R)-2 via Sharpless asymmetric epoxidation in >96% ee. Regiospecific epoxide ring opening and reduction of the intermediate alkyne set the stage for a one-pot lactonization to give (R)-6, a convenient precursor for all functionalized chiral DAG-lactones used as potent PK-C ligands. The synthesis of the most potent DAG-lactones known to date, (Z)-10 and (E)-10, served to confirm PK-C's exclusive preference for the (R)-stereochemistry in this class of compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15228292     DOI: 10.1021/ol0492041

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  9 in total

1.  Synthesis and Biological Evaluation of Several Bryostatin Analogues Bearing a Diacylglycerol Lactone C-Ring.

Authors:  David O Baumann; Kevin M McGowan; Noemi Kedei; Megan L Peach; Peter M Blumberg; Gary E Keck
Journal:  J Org Chem       Date:  2016-08-23       Impact factor: 4.354

2.  The triphosphate of beta-D-4'-C-ethynyl-2',3'-dideoxycytidine is the preferred enantiomer substrate for HIV reverse transcriptase.

Authors:  Maqbool A Siddiqui; Victor E Marquez
Journal:  Bioorg Med Chem       Date:  2006-09-29       Impact factor: 3.641

3.  Conformationally constrained analogues of diacylglycerol (DAG). 25. Exploration of the sn-1 and sn-2 carbonyl functionality reveals the essential role of the sn-1 carbonyl at the lipid interface in the binding of DAG-lactones to protein kinase C.

Authors:  Ji-Hye Kang; Megan L Peach; Yongmei Pu; Nancy E Lewin; Marc C Nicklaus; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2005-09-08       Impact factor: 7.446

4.  Exploring the influence of indololactone structure on selectivity for binding to the C1 domains of PKCα, PKCε, and RasGRP.

Authors:  Eleonora Elhalem; Lucía Gandolfi Donadío; Xiaoling Zhou; Nancy E Lewin; Lia C Garcia; Christopher C Lai; James A Kelley; Megan L Peach; Peter M Blumberg; María J Comin
Journal:  Bioorg Med Chem       Date:  2017-03-10       Impact factor: 3.641

5.  Conformationally constrained analogues of diacylglycerol. 30. An investigation of diacylglycerol-lactones containing heteroaryl groups reveals compounds with high selectivity for Ras guanyl nucleotide-releasing proteins.

Authors:  Saïd El Kazzouli; Nancy E Lewin; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2008-08-16       Impact factor: 7.446

6.  PKCalpha activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo.

Authors:  Jean-Philip Truman; Susan A Rotenberg; Ji-Hye Kang; Gabriel Lerman; Zvi Fuks; Richard Kolesnick; Victor E Marquez; Adriana Haimovitz-Friedman
Journal:  Cancer Biol Ther       Date:  2009-01-04       Impact factor: 4.742

Review 7.  Wealth of opportunity - the C1 domain as a target for drug development.

Authors:  P M Blumberg; N Kedei; N E Lewin; D Yang; G Czifra; Y Pu; M L Peach; V E Marquez
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

8.  Diacylglycerol lactones targeting the structural features that distinguish the atypical C1 domains of protein kinase C ζ and ι from typical C1 domains.

Authors:  Yongmei Pu; Ji-Hye Kang; Dina M Sigano; Megan L Peach; Nancy E Lewin; Victor E Marquez; Peter M Blumberg
Journal:  J Med Chem       Date:  2014-04-17       Impact factor: 7.446

Review 9.  PKC in Regenerative Therapy: New Insights for Old Targets.

Authors:  Marta Rui; Rita Nasti; Emanuele Bignardi; Serena Della Volpe; Giacomo Rossino; Daniela Rossi; Simona Collina
Journal:  Pharmaceuticals (Basel)       Date:  2017-05-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.